243 related articles for article (PubMed ID: 9484989)
1. Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis.
Mustonen P; Lepäntalo M; Lassila R
Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):244-9. PubMed ID: 9484989
[TBL] [Abstract][Full Text] [Related]
2. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
Kario K; Matsuo T
Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
[TBL] [Abstract][Full Text] [Related]
3. Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase.
Szabo S; Letsch R; Ehlers R; Walter T; Kazmaier S; Helber U; Hoffmeister HM
Thromb Res; 2002 Apr; 106(2):113-9. PubMed ID: 12182909
[TBL] [Abstract][Full Text] [Related]
4. Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activator.
Gram J; Munkvad S; Leebeek FW; Kluft C; Jespersen J
Coron Artery Dis; 1993 Apr; 4(4):371-7. PubMed ID: 8261210
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
van der Bom JG; Bots ML; Haverkate F; Meyer P; Hofman A; Grobbee DE; Kluft C
Thromb Haemost; 1999 Feb; 81(2):275-80. PubMed ID: 10064006
[TBL] [Abstract][Full Text] [Related]
6. Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices.
Koyama T; Kakishita E; Nakai Y; Okamoto E
Am J Hematol; 1991 Oct; 38(2):90-4. PubMed ID: 1719808
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
[TBL] [Abstract][Full Text] [Related]
8. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
[TBL] [Abstract][Full Text] [Related]
9. Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction.
Gyöngyösi M; Glogar D; Weidinger F; Domanovits H; Laggner A; Wojta J; Zorn G; Iordanova N; Huber K
Am Heart J; 2004 Jan; 147(1):158-64. PubMed ID: 14691435
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
[TBL] [Abstract][Full Text] [Related]
11. Performance evaluation of thrombomodulin, thrombin-antithrombin complex, plasmin-α2-antiplasmin complex, and t-PA: PAI-1 complex.
Chen Q; Shou W; Wu W; Wang G; Cui W
J Clin Lab Anal; 2019 Jul; 33(6):e22913. PubMed ID: 31090232
[TBL] [Abstract][Full Text] [Related]
12. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
Malyszko J; Malyszko JS; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
Thromb Res; 1996 Sep; 83(5):351-61. PubMed ID: 8873344
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis system in patients with bronchial asthma.
Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
Med Sci Monit; 2000; 6(1):103-7. PubMed ID: 11208294
[TBL] [Abstract][Full Text] [Related]
14. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.
Tohgi H; Takahashi H; Chiba K; Tamura K
Stroke; 1993 Jun; 24(6):801-4. PubMed ID: 8506551
[TBL] [Abstract][Full Text] [Related]
15. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
16. Thrombin and plasmin generation in patients with liver disease.
Takahashi H; Tatewaki W; Wada K; Yoshikawa A; Shibata A
Am J Hematol; 1989 Sep; 32(1):30-5. PubMed ID: 2527002
[TBL] [Abstract][Full Text] [Related]
17. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
Koike K; Fujimaki M
Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526
[TBL] [Abstract][Full Text] [Related]
18. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
[TBL] [Abstract][Full Text] [Related]
19. Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics.
Fujii Y; Sugawa C; Ozawa T; Nakumura R; Brown-Castillo J; Mammen EF
Am Surg; 1991 Apr; 57(4):222-5. PubMed ID: 1711300
[TBL] [Abstract][Full Text] [Related]
20. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction.
Kamikura Y; Wada H; Yamada A; Shimura M; Hiyoyama K; Shiku H; Tanigawa M; Nishikawa H; Yamada N; Isaka N; Nakano T; Kumeda K; Kato H
Am J Hematol; 1997 Aug; 55(4):183-7. PubMed ID: 9257877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]